Nature Medicine · Published 2026-07-01 · DOI 10.1038/s41591-026-04475-7
Michael Lim, Xiaobu Ye, Anna F. Piotrowski, Arati Desai, Manmeet S Ahluwalia, Tobias Walbert, Glenn Lesser, Benjamin M. Ellingson, David M. Peereboom, Joy D. Fisher, Serena Desideri, Christina Jackson, Ayush Pant, Aanchal Jain, Rohit Verma, Benjamin Oberlton, Hadeesha Piyadasa, Chetan Bettegowda, Logan Engle, Janis Taube, Sean C. Bendall, John Choi, Jan Drappatz, Frank S. Lieberman, Lawrence R. Kleinberg, Drew M. Pardoll, Louis B. Nabors, Patrick Y. Wen, Stuart A. Grossman
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Lim, M., Ye, X., Piotrowski, A., et al. (2026). Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04475-7